Fluorescent, Plasmonic, and Radiotherapeutic Properties of the 177Lu–Dendrimer-AuNP–Folate–Bombesin Nanoprobe Located Inside Cancer Cells. Mendoza-Nava et al. Mol Imaging. 2017 Jan-Dec; 16: 1536012117704768

The Beginning and Development of the Theranostic Approach in Nuclear Medicine, as Exemplified by the Radionuclide Pair 86Y and 90Y. Frank Rösch, Hans Herzog, Syed M. Qaim. Pharmaceuticals 2017, 10(2), 56; doi:10.3390/ph10020056

New methodologies for the preparation of carbon-11 labeled radiopharmaceuticals. Kenneth Dahl, Christer Halldin, Magnus Schou. Clin Transl Imaging. 2017; 5(3): 275–289; doi: 10.1007/s40336-017-0223-1

Four patients with gastrointestinal bleeding identified by a modified in vivo technique with labeled red blood cells sedimentation. Kang-Hung Chao et al. Hellenic Journal of Nuclear Medicine. January-April 2017

Synthesis and pre-clinical evaluation of a new class of high-affinity 18F-labeled PSMA ligands for detection of prostate cancer by PET imaging. Kelly, J., Amor-Coarasa, A., Nikolopoulou, A. et al. Eur J Nucl Med Mol Imaging (2017) 44: 647. doi:10.1007/s00259-016-3556-5

Targets and probes for non-invasive imaging of β-cells. Jodal, A., Schibli, R. & Béhé, M. Eur J Nucl Med Mol Imaging (2017) 44: 712. doi:10.1007/s00259-016-3592-1

44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617 Umbricht et al. EJNMMI Research (2017) 7:9

In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan. Anxo Fernández-Ferreiro et al. Eur J Pharm Biopharm, 114: 317–323, mayo 2017

New methodologies for the preparation of carbon-11 labeled radiopharmaceuticals Kenneth Dahl, Christer Halldin, Magnus Schou.Clinical and Translational Imaging, 2017

A practical and pyrogen-free preparation of 11C-L-methionine in a good manufacturing practice-compliant approach. Li KP, Hu MK, Cheng CY, Hsu LF, Chou TK, Shiue CY, Shen DHJ Med Sci 2017;37:7-11ç

223Ra-dichloride spectrometric characterization: Searching for the presence of long-lived isotopes with radiological protection implications. European Journal of Medical Physics.Feb 2017

[ 68Ga]NOTA-Galactosyl Human Serum Albumin: a Tracer for Liver Function Imaging with Improved StabilityMolecular Imaging and Biology, 2017 Feb

Rapid Synthesis of 68Ga-labeled macroaggregated human serum albumin (MAA) for routine application in perfusion imaging using PET/CT. Mueller D, Kulkarni H, Baum RP, Odparlik A.  Appl Radiat Isot. 2017 Jan 9;122:72-77

Potential ways to address shortage situations of Mo-99/Tc-99m. Filzen L, Ellingson L, Paulsen A, Hung J. J Nucl Med Technol. 2017 Feb 2.

68Ga-prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Prostate Cancer Imaging: A Narrative Literature Review. Oliveira JM, Gomes C, Faria DB, Vieira TS, Silva FA, Vale J,  World J Nucl Med 2017;16:3-7.

SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic. X.Wang et alia. Oncotarget, Jan 2017.

Are we “preparing” radiopharmaceuticals? Decristoforo, C. & Patt, M. EJNMMI radiopharm. chem. (2017) 1: 12

Consequences of radiopharmaceutical extravasation and therapeutic interventions: a systematic review, van der Pol J, Vöö S, Bucerius J, Mottaghy FM,Eur J Nucl Med Mol Imaging. 2017 Mar 16

Uso de solventes no acuosos en la síntesis del radioconjugado DOTA-1-Nal3 -octreotida marcado con galio-68. Marylaine Pérez-Malo Cruz, René Leyva Montaña, José Morín Zorrilla. Nucleus- Ciencias Nucleares.nº 59. Cuba.2016

Alteraciones en la biodistribución de los radiofármacos causadas por interacciones medicamentosas

ALASBIMN Journal 4 de mayo de 2012

A Review on Therapeutic Approach of Radiopharmaceutical in Health Care System

International Journal of Pharmaceutical & Biological Archives 2012; 3(3):487-492

Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine – a review

Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2269-81

The options for the future production of the medical isotope 99Mo

Eur J Nucl Med Mol Imaging (2010) 37:1817–1820

Development of a Comprehensive Software Application for Calculations in Nuclear Medicine and Radiopharmacy

J Nucl Med Technol. 2010 Sep;38(3):153-62.

Aplicación de los factores de ponderación de la Comisión Internacional de Protección Radiológica 103 en el cálculo de la dosis efectiva asociada a las exploraciones de Medicina Nuclear

 Rev Esp Med Nucl. 2010 May-June;29(3):114-121.

Q J Nucl Med Mol Imaging. 2006 Jun;50(2):147-52.

Control de calidad de activímetros

Rev Esp Med Nucl. 2004;23(6):434-43.

Alternative quality control for technetium-99m IDA complexes

Applied radiation and isotopes. 2004;61:1151-55.

Método rápido de marcaje de leucocitos con 99mTc-HMPAO

Rev Esp Med Nucl. 2002;21(5):343-8.

Radiofármacos PET

Rev Esp Med Nucl. 2001;20(3):477-98.

Labelling of platelets with indium-111 oxine and technetium-99m HMPAO: suggested methods

Eur J Nucl Med. 1999;26(12):1614-1616.

Drug interactions with radiopharmaceuticals

Eur J Nucl Med. 1994;21:348-356


Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información